Literature DB >> 1567388

Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation.

S S Kakar1, J C Sellers, D C Devor, L C Musgrove, J D Neill.   

Abstract

A rat angiotensin, type 1A (AT1A) receptor cDNA was cloned recently and shown to be a member of the 7-transmembrane, G-protein coupled family of receptors. Here, we report the cloning, sequencing, and expression of a previously unsuspected second form of the type 1 receptor (AT1B) in the rat which exhibits high similarity with the AT1A receptor relative to amino acid sequence (95% identity), binding of angiotensin II analogs, and utilization of Ca+2 as its intracellular second messenger. The adrenal and pituitary gland express primarily AT1B mRNA whereas vascular smooth muscle and lung express primarily AT1A mRNA. Estrogen treatment suppressed AT1B but not AT1A mRNA levels in the pituitary gland. Thus, the unexpected existence of two putative AT1 receptor genes appears to be related to the differential regulation of their expression rather than to different functional properties of the encoded receptor proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567388     DOI: 10.1016/s0006-291x(05)80302-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Angiotensin receptor II is present in dopaminergic cell line of rat substantia nigra and it is down regulated by aminochrome.

Authors:  A Dagnino-Subiabre; K Marcelain; C Arriagada; I Paris; P Caviedes; R Caviedes; J Segura-Aguilar
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 2.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

3.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  QTL mapping for traits associated with stress neuroendocrine reactivity in rats.

Authors:  Bastien Llamas; Vincent Contesse; Véronique Guyonnet-Duperat; Hubert Vaudry; Pierre Mormède; Marie-Pierre Moisan
Journal:  Mamm Genome       Date:  2005-07       Impact factor: 2.957

Review 6.  The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain.

Authors:  Robert C Speth; Vardan T Karamyan
Journal:  Heart Fail Rev       Date:  2008-01-09       Impact factor: 4.214

Review 7.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

8.  Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells.

Authors:  A J Balmforth; S E Bryson; A J Aylett; P Warburton; S G Ball; K T Pun; D Middlemiss; G M Drew
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 9.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

10.  Six commercially available angiotensin II AT1 receptor antibodies are non-specific.

Authors:  Julius Benicky; Roman Hafko; Enrique Sanchez-Lemus; Greti Aguilera; Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2012-07-28       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.